Brief: HCW Biologics Inc Reports Quarterly Net Loss Per Share Of $0.11

Hcw Biologics

07/11/2022 22:14

Nov 7 (Reuters) - HCW Biologics Inc  HCWB.O :
    * HCW BIOLOGICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
    * HCW BIOLOGICS INC - AS OF SEPTEMBER 30, 2022, COMPANY HAD
CASH
AND CASH EQUIVALENTS AND INVESTMENTS OF $35.9 MILLION
    * HCW BIOLOGICS INC - QTRLY REVENUES OF $1.8 MILLION, THERE
WERE
NO REVENUES IN THREE-MONTH PERIOD ENDED SEPTEMBER 30, 2021
    * HCW BIOLOGICS INC - QTRLY NET LOSS PER SHARE OF $0.11
    * HCW BIOLOGICS INC - COMPANY ESTIMATES THAT CURRENT CASH
BALANCE
IS SUFFICIENT TO FUND OPERATIONS AND CAPITAL EXPENDITURES
THROUGH END OF 2023

Source text for Eikon:  ID:nGNX9MJrw4 
Further company coverage:  HCWB.O 
 ((Reuters.Briefs@thomsonreuters.com;;))